TrialMedicine2017

Efficacy of 1st-line bismuth-containing quadruple therapies with levofloxacin or clarithromycin for the eradication of Helicobacter pylori infection: A 1-week, open-label, randomized trial.

Jing Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.